Shrivastava Sandeep, Patel Siddharth, Pundkar Aditya, Jaiswal Ankit, Shrivastava Priyal
Department of Orthopaedics, J.N. Medical College, Datta Meghe Institute of Higher Education, Wardha, Maharashtra India.
Indian J Orthop. 2024 Jun 24;58(8):1043-1052. doi: 10.1007/s43465-024-01212-5. eCollection 2024 Aug.
Autologous platelet-rich plasma (PRP) therapy has emerged as a promising regenerative treatment modality, offering potential improvements in healing outcomes through its rich content of growth factors and cytokines. We evaluated the effectiveness of PRP therapy in the management of complex wounds, using a decade-long retrospective analysis of treatments conducted at a tertiary care center from 2010 to 2020. The study introduces and assesses the efficacy of the Sandeep's Technique for Assisted Regeneration of Skin (STARS) in enhancing wound healing and quality of life for patients with complex wounds.
A prospective interventional study was conducted, involving two phases: the development and initial testing of PRP therapy (2010-2015) and the application and evaluation of the STARS protocol (2015-2020). The study included patients with complex wounds, utilizing autologous PRP prepared through a double spin centrifuge technique. Outcome measures included wound-healing rates, infection management, and complication rates, compared to conventional treatment methods.
The study treated 500 wounds in 432 patients with autologous PRP, noting significant improvements in wound-healing rates, 97.7% had infection control without antibiotics (even in MRSA cases), and all had a good pain control. Histopathological examinations confirmed collagen-rich healing with minimal scarring. The STARS protocol demonstrated the potential of PRP therapy in accelerating wound healing, reducing the need for additional surgical interventions, and enhancing patient outcomes.
PRP therapy, particularly when administered following the STARS protocol, represents a safe, effective, and patient-friendly approach for the management of complex wounds. This study supports the integration of PRP therapy into regenerative care strategies, suggesting a shift toward more innovative and efficacious treatments in wound management.
自体富血小板血浆(PRP)疗法已成为一种有前景的再生治疗方式,通过其丰富的生长因子和细胞因子含量,有望改善愈合效果。我们通过对2010年至2020年在一家三级护理中心进行的治疗进行长达十年的回顾性分析,评估了PRP疗法在复杂伤口管理中的有效性。该研究介绍并评估了桑迪普皮肤辅助再生技术(STARS)在促进复杂伤口患者伤口愈合和提高生活质量方面的疗效。
进行了一项前瞻性干预研究,包括两个阶段:PRP疗法的开发和初步测试(2010 - 2015年)以及STARS方案的应用和评估(2015 - 2020年)。该研究纳入了复杂伤口患者,使用通过双旋转离心技术制备的自体PRP。与传统治疗方法相比,结果指标包括伤口愈合率、感染管理和并发症发生率。
该研究用自体PRP治疗了432例患者的500处伤口,伤口愈合率有显著改善,97.7%的患者在未使用抗生素的情况下实现了感染控制(即使在耐甲氧西林金黄色葡萄球菌病例中),且所有患者疼痛控制良好。组织病理学检查证实愈合过程中胶原蛋白丰富,疤痕最小。STARS方案证明了PRP疗法在加速伤口愈合、减少额外手术干预需求以及改善患者预后方面的潜力。
PRP疗法,特别是按照STARS方案给药时,是一种用于复杂伤口管理的安全、有效且对患者友好的方法。这项研究支持将PRP疗法纳入再生护理策略,表明在伤口管理方面正朝着更具创新性和有效性的治疗方法转变。